COMMUNIQUÉS West-GlobeNewswire

electroCore Announces Full Year 2024 Financial Results

12/03/2025 - 21:05

Record f ull year 2024 net sales of $ 25.2 million increased 57% over $16.0 million for the full year 2023 driven by 85% annual growth of Rx gammaCore TM in the United States Department of Veteran Affairs and United [...]

Assertio Reports Fourth Quarter and Full Year 2024 Financial Results

12/03/2025 - 21:05

Fourth Quarter Net Product Sales $29.6 Million, Cash Flow from Operations of $11.5 Million Full Year Net Product Sales $120.8 Million, Rolvedon Sales Exceed $60.0 Million Full Year Cash Flow from Operations of $26.4 [...]

BeautyHealth Reports Full Year and Fourth Quarter 2024 Financial Results

12/03/2025 - 21:05

Delivers fourth quarter and full year net sales of $83.5 million and $334.3 million LONG BEACH, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth”), home to flagship [...]

Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update

12/03/2025 - 21:02

- Interim results from three trials exploring the use of Alpha DaRT ® in treating pancreatic cancer showing high disease control rate, impressive overall survival in sub-group analyses, and positive safety profile - - [...]

Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results

12/03/2025 - 21:02

SAN CARLOS, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company that has been developing antibodies for the treatment of allergic, inflammatory and [...]

scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025

12/03/2025 - 21:01

Management to host conference call and webcast, after-market on March 19, 2025, at 4:30 p.m. ET BURLINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company [...]

Kalaris and AlloVir Announce Stockholder Approval of Merger

12/03/2025 - 21:01

Combined company expected to trade on Nasdaq under “KLRS” after closing PALO ALTO, Calif. and LEXINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. (“Kalaris”), a clinical-stage [...]

Xenon to Present at Stifel 2025 Virtual CNS Forum

12/03/2025 - 21:01

VANCOUVER, British Columbia and BOSTON, March 12, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering [...]

Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025

12/03/2025 - 21:00

HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will [...]

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

12/03/2025 - 21:00

JUPITER, Fla., March 12, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company focused on the efficient large-scale manufacture of [...]

aTyr Pharma Announces Publication Demonstrating Efzofitimod’s Immunomodulatory Activity in Science Translational Medicine

12/03/2025 - 21:00

Peer-reviewed publication validates efzofitimod’s unique anti-inflammatory mechanism of action on macrophages through neuropilin-2 (NRP2) receptor. Scientific insights further strengthen the rationale for clinical [...]

ACTG Presents Study at CROI Demonstrating Potential of CMV-specific Antiviral Inhibitor to Improve Aging-Related Outcomes among People Living with HIV and CMV (Cytomegalovirus)

12/03/2025 - 20:00

LOS ANGELES, March 12, 2025 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented promising findings from a study exploring how treating asymptomatic [...]

ACTG Presents Important Findings from REPRIEVE at CROI 2025

12/03/2025 - 20:00

Presentations Address Frailty, Inflammation, Asymptomatic Heart Muscle Damage, and Mental Function LOS ANGELES, March 12, 2025 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other [...]

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

12/03/2025 - 19:19

Company Announcement COPENHAGEN, Denmark; March 12, 2025 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]

Bad Science Used to Support Regulations, According to the Journal of American Physicians and Surgeons

12/03/2025 - 19:14

TUCSON, Ariz., March 12, 2025 (GLOBE NEWSWIRE) -- Governments issue regulations with tremendous impact on the economy and on health practices. These regulations are based on published scientific research. But there is a [...]

Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab

12/03/2025 - 19:13

Company Announcement COPENHAGEN, Denmark; March 12, 2025 – Genmab A/S (Nasdaq: GMAB) Following Genmab A/S’ Annual General Meeting held on March 12, 2025, the Company’s Board of Directors met to constitute itself. Ms. [...]

MEDIA ADVISORY: Health Coalition to announce response to court rulings on Bill 7 Charter Challenge and Orchard Villa case

12/03/2025 - 18:20

TORONTO, March 12, 2025 (GLOBE NEWSWIRE) -- The courts have ruled on two cases impacting thousands of elderly hospital patients and long-term care residents in Ontario and the Ontario Health Coalition is holding a press [...]

EUROBIO SCIENTIFIC ÉTEND SA PRÉSENCE EN ITALIE

12/03/2025 - 17:35

EUROBIO SCIENTIFIC ÉTEND SA PRÉSENCE EN ITALIE Acquisition de l'unité Life Science de Voden Medical Instruments Spa Finalisation de l'acquisition de Quimark SRL Décision du fournisseur T2 Biosystems d'arrêter la [...]

EUROBIO SCIENTIFIC INCREASES ITS FOOTPRINT IN ITALY

12/03/2025 - 17:35

EUROBIO SCIENTIFIC INCREASES ITS FOOTPRINT IN ITALY Signing of the acquisition of Life Science unit of Voden Medical Instruments Spa Completion of the acquisition of Quimark SRL Decision of supplier T2 Biosystems to [...]